Clinical Trial Update: Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial of pembrolizumab for advanced penile squamous cell carcinoma has been terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Squamous Cell Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Penile Squamous Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2022-06-21